{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:34Z","timestamp":1791499294995,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L023687\/1"],"award-info":[{"award-number":["BB\/L023687\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["ETM\/182"],"award-info":[{"award-number":["ETM\/182"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.biopha.2019.01.020","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T16:37:56Z","timestamp":1547915876000},"page":"1408-1416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line"],"prefix":"10.1016","volume":"111","author":[{"given":"Katie","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Kozlowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Brzeszczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Treskes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-0753","authenticated-orcid":false,"given":"Kay","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4197-4843","authenticated-orcid":false,"given":"Lenny","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bagnaninchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-5652","authenticated-orcid":false,"given":"Joanna","family":"Brzeszczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Plevris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2019.01.020_bib0005","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Antherieu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2019.01.020_bib0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hep.1840130204","article-title":"Cholestasis and changes of portal pressure caused by chlorpromazine in the perfused rat liver","volume":"13","author":"Akerboom","year":"1991","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2019.01.020_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03260010","article-title":"Drug-induced cholestasis","volume":"2","author":"Zimmerman","year":"1987","journal-title":"Med. Toxicol."},{"key":"10.1016\/j.biopha.2019.01.020_bib0020","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"Moradpour","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2019.01.020_bib0025","series-title":"In vitro Methods in Pharmaceutical Research","first-page":"375","article-title":"In vitro investigation of the molecular mechanisms of hepatotoxicity","author":"Castell","year":"1996"},{"issue":"8","key":"10.1016\/j.biopha.2019.01.020_bib0030","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.tiv.2012.05.008","article-title":"Optimization of the HepaRG cell model for drug metabolism and toxicity studies","volume":"26","author":"Antherieu","year":"2012","journal-title":"Toxicol. Vitr."},{"issue":"1","key":"10.1016\/j.biopha.2019.01.020_bib0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bcpt.12631","article-title":"Human hepatic HepaRG cells maintain and organotypic phenotype with high intrinsic CYP450 activity\/metabolism and significantly outperform standard HepG2\/C3A cells for pharmaceutical and therapeutic applications","volume":"120","author":"Nelson","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2019.01.020_bib0040","doi-asserted-by":"crossref","first-page":"37541","DOI":"10.1038\/srep37541","article-title":"Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver","volume":"7","author":"Gamal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2019.01.020_bib0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/excr.2000.4919","article-title":"Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces","volume":"259","author":"Wegener","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2019.01.020_bib0050","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1073\/pnas.88.17.7896","article-title":"Micromotion of mammalian cells measured electrically","volume":"88","author":"Giaever","year":"1991","journal-title":"Natl. acad Sci"},{"issue":"3","key":"10.1016\/j.biopha.2019.01.020_bib0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0033291700015841","article-title":"Clinical significance of plasma chlorpromazine levels I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment","volume":"6","author":"Wiles","year":"1976","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.01.020_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1970.01740280001001","article-title":"Chlorpromazine plasma levels and effects","volume":"22","author":"Curry","year":"1970","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2019.01.020_bib0065","series-title":"ACuteTox-Research Project for Alternative Testing","author":"ACUTETOX","year":"2004"},{"key":"10.1016\/j.biopha.2019.01.020_bib0070","series-title":"Disposition of Toxic Drugs and Chemicals in Man","first-page":"158","author":"Baselt","year":"1995"},{"issue":"6","key":"10.1016\/j.biopha.2019.01.020_bib0075","first-page":"1759","article-title":"Hepatic differentiation of human iPSCs in different 3D models: a comparative study","volume":"40","author":"Meier","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2019.01.020_bib0080","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2019.01.020_bib0085","series-title":"Reference Gene Validation Software for Improved Normalization, Real-time PCR: Current Technology and Applications","author":"Vandesompele","year":"2009"},{"issue":"5","key":"10.1016\/j.biopha.2019.01.020_bib0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.apsb.2016.07.003","article-title":"Crosstalk of HNF4\u03b1 with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids","volume":"6","author":"Lu","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.biopha.2019.01.020_bib0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)32167-1","article-title":"Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver","volume":"214","author":"Tavoloni","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2019.01.020_bib0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.01.020_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfv041","article-title":"Comparative localization and functional activity of the main hepatobiliary transporters in HepaRG cells and primary human hepatocytes","volume":"145","author":"Bachour El-Azzi","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2019.01.020_bib0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-60327-412-8_24","article-title":"High-quality immunofluorescence of cultured cells","volume":"619","author":"Bhattacharyya","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2019.01.020_bib0115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9343(59)90188-3","article-title":"Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis): a serial study of twenty-six needle biopsy specimens in nine patients","volume":"27","author":"Zelman","year":"1959","journal-title":"Am. J. Med."},{"issue":"29","key":"10.1016\/j.biopha.2019.01.020_bib0120","doi-asserted-by":"crossref","first-page":"47861","DOI":"10.18632\/oncotarget.18136","article-title":"An ultra-sensitive biophysical risk assessment of light effect on skin cells","volume":"8","author":"Bennet","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.biopha.2019.01.020_bib0125","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1039\/C5AN00979K","article-title":"Evaluation of UV radiation-induced toxicity and biophysical changes in various skin cells with photo-shielding molecules","volume":"140","author":"Bennet","year":"2015","journal-title":"Analyst"},{"issue":"10","key":"10.1016\/j.biopha.2019.01.020_bib0130","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1021\/ac303068t","article-title":"Impedance-based cell culture platform to assess light-induced stress changes with antagonist drugs using retinal cells.(Author abstract)","volume":"85","author":"Bennet","year":"2013","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2019.01.020_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1165\/rcmb.2008-0302OC","article-title":"IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins","volume":"41","author":"Waxman","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2019.01.020_bib0140","article-title":"Acidic bile salts modulate the squamous epithelial barrier function by modulating tight junction proteins","volume":"301","author":"Chen","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2019.01.020_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.2006.092742","article-title":"Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene","volume":"56","author":"Wasmuth","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2019.01.020_bib0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ejhg.2011.186","article-title":"First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis","volume":"20","author":"Pasmant","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.biopha.2019.01.020_bib0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2012.01.025","article-title":"ABCB4\/MDR3 gene mutations and cholangiocarcinomas","volume":"57","author":"Tougeron","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2019.01.020_bib0160","doi-asserted-by":"crossref","first-page":"11823","DOI":"10.1038\/s41598-017-11626-x","article-title":"An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy","volume":"7","author":"Dixon","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218372676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218372676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:47:15Z","timestamp":1760096835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218372676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":32,"alternative-id":["S0753332218372676"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.01.020","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}